C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
11/2007
11/15/2007	US20070265455 light absorbers; heat resistance; high speed recording
11/15/2007	US20070265348 Therapeutic guanidines
11/15/2007	US20070265317 Preparation of 3-[3-(Crotonylsulfanylmethylcarbonyloxy)-4-methoxyphenyl]-1-(3,4,5-trimethoxyphenyl)propenone (CMAC-1); breast, colon and colorectal, leukemia, pancreatic, central nervous system, non-small-cell lung, ovarian, prostate, melanoma, renal, fibrosarcoma, and urinary bladder cancer cells
11/15/2007	US20070265301 Dpp-IV Inhibitors
11/15/2007	US20070265300 Pyridine Derivatives of Alkyl Oxindoles as 5-Ht7 Receptor Active Agents
11/15/2007	US20070265281 Organic Compounds and Their Uses
11/15/2007	US20070265278 2-phenyl-indoles as prostaglandin d2 receptor antagonists
11/15/2007	US20070265266 Active Agents Combination Exhibiting Insecticidal and Acaricide Properties
11/15/2007	US20070265254 Naphthaline derivatives as H3 inverse agonists
11/15/2007	US20070265248 Substituted piperazines and methods of use
11/15/2007	US20070264196 Modulators of ATP-binding cassette transporters
11/15/2007	US20070262704 Carbazole-based Compounds and Their Application
11/15/2007	US20070262703 2,2'-Disubstituted 9,9'-Spirobifluorene-based Triaryldiamines and Their Application
11/15/2007	CA2652215A1 Crystalline (3-cyano-1h-indol-7-yl)-[4-(4-fluorophenethyl)piperazin-1-yl]methanone phosphate
11/15/2007	CA2649677A1 Tetrasubstituted ureas as modulators of 11-.beta. hydroxyl steroid dehydrogenase type 1
11/15/2007	CA2641405A1 Production process for bicyclic tetrahydropyrrole compounds
11/15/2007	CA2641100A1 Bicyclic tetrahydropyrrole compounds
11/15/2007	CA2640806A1 Bicyclic tetrahydropyrrole compounds
11/14/2007	EP1853589A1 Process for preparing 2,3-disubstituted indoles
11/14/2007	EP1853551A1 Process and methods for the preparation of gabapentin and its intermediates
11/14/2007	CN101072780A Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
11/14/2007	CN101072779A 2,4 (4,6) pyrimidine derivatives
11/14/2007	CN101072754A 9,9'- and 2,2'-substituted 3,3'-bicarbazolyl derivatives for use in semiconducting materials as a host matrix for phosphorescent emitters
11/14/2007	CN101072753A Process for the preparation of carvedilol and its enantiomers
11/14/2007	CN101070316A Di-aryl acid derivatives as ppar receptor ligands
11/14/2007	CN101070309A Substituted piperazines (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
11/14/2007	CN101070302A Synthesis of phenolic monomers containing imide or diimide moieties and high heat carbonate polymers prepared therefrom
11/14/2007	CN100348580C Taxol enhancer compounds
11/14/2007	CN100348569C Induction of apoptosis in cancer cells
11/13/2007	US7294648 Anthranyl derivatives having an anticholecystokinin activity (anti-cck-1), a process for their preparation, and pharmaceutical use thereof
11/13/2007	US7294647 Kappa agonist compounds and pharmaceutical formulations thereof
11/13/2007	US7294642 1,3-Diamino-2-hydroxypropane pro-drug derivatives
11/13/2007	CA2213080C 1-aryl-2-acylamino-ethane compounds and their use as neurokinin especially neurokinin 1 antagonists
11/08/2007	WO2007127763A2 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/08/2007	WO2007127731A1 4-squarylpiperazine derivatives as antiviral agents
11/08/2007	WO2007127421A2 Process for the synthesis of (+) and (-)-1-aryl-3-azabicyclo[3.1.0]hexanes
11/08/2007	WO2007126889A1 Preparation of tegaserod acetate
11/08/2007	WO2007126020A1 Compound having activity of blocking nmda receptor channel, and pharmaceutical agent using the same
11/08/2007	WO2007125934A1 Anthracene derivative, and light-emitting element, light-emitting device, electronic device using anthracene derivative
11/08/2007	WO2007125547A2 Novel process for statins and its pharmaceutically acceptable salts thereof
11/08/2007	WO2007124543A1 Profluorescent nitroxide compounds
11/08/2007	WO2007084450A3 Cannibinoid receptor modulators
11/08/2007	WO2007084435A3 Methods for treating hepatitis c
11/08/2007	WO2006119148A3 Keratinocyte growth factor receptor - tyrosine specific inhibitors for the prevention of cancer metastatis
11/08/2007	US20070260025 [Dimethylsilanediyl(2-methyl-8-phenylbenzo[b]cyclopenta[d]-thien-3-ylidene)2]zirconium(IV) dichloride; for homo- and copolymerization of propylene; useful for producing hard and stiff shaped bodies having high ultimate tensile strength, e.g. fibers, filaments, injection-molded parts, films, plates
11/08/2007	US20070259946 N-(isoquinol-5-yl)-5-fluoro-1-[((3-trifluoromethyl)phenyl)methyl]-1H-indole-2-carboxamide; transient receptor potential vanilloid (capsaicin receptor) antagonist or agonist; analgesic, antiallergen agent; pain and irritation of the skin, eyes and mucous membrane
11/08/2007	US20070259945 Method for treating pain
11/08/2007	US20070259944 Amides such as 5-(3-Nitrophenyl)-1,3-dihydro-indol-2-one, used as antiprogesterones, contraceptives, for hormone replacement therapy during menopause and as anticarcinogenic agents
11/08/2007	US20070259943 Ortho-substituted pentafluorosulfanyl benzenes, method for the production thereof and their use as synthesis intermediates
11/08/2007	US20070259942 Indolone derivatives like N2-[2-(5-Methyl-1H-3-indolyl)ethyl]-N4-(4-methylphenyl)-6-(1-piperidinyl)-2,4-pyrimidinediamine; galanin-type receptors; antidepressants; anxiolytic agents
11/08/2007	US20070259940 Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment
11/08/2007	US20070259922 Aryl, aryloxy, alkyloxy substituted 1H-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
11/08/2007	US20070259910 3-{4-[3-(2-Fluoro-5-trifluoromethylphenyl)ureido]phenyl}-1H-indole-2-carboxamide;KDR (Kinase insert Domain Receptor), Tie-2 and FAK tyrosine kinase receptor inhibitors; anticarcinogenic agents; psoriasis; antiinflammatory agents; antiarthritic agents; antidiabetic agents; Kaposi's sarcoma; hemangiomas
11/08/2007	US20070259872 Inhibitors of soluble adenylate cyclase
11/08/2007	US20070259871 Hydroxybenzamide Derivatives And Their Use As Inhibitors Of HSP90
11/08/2007	US20070259294 Cyanine Compound and Optical Recording Materials
11/08/2007	CA2648019A1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
11/07/2007	EP1852420A1 Indole compound and use thereof
11/07/2007	EP1851200A2 Dimeric iap inhibitors
11/07/2007	EP1851199A1 Substituted bis aryl and heteroaryl compounds as selective 5ht2a antagonists
11/07/2007	EP1773814B1 Substituted oxindol derivatives and medicaments containing the same
11/07/2007	EP1042288B1 Tripeptidyl peptidase inhibitors
11/07/2007	CN101068809A Substituted indole compounds and their use as 5-ht6 receptor modulators
11/07/2007	CN101068781A Compounds for alzheimer's disease
11/07/2007	CN101068772A N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
11/07/2007	CN100347171C Pyridine compounds and their prepn and application as Dopamine D4 receptor agonist
11/07/2007	CN100347158C Bicyclic compound
11/07/2007	CN100347151C Novel aminobenzoephenones
11/07/2007	CN100346779C Liquid pharmaceutical composition
11/06/2007	USRE39916 Compounds that modulate PPAR activity and methods for their preparation
11/06/2007	US7291745 Process for the preparation of perindopril
11/06/2007	US7291732 Isomeric fused pyrrolocarbazoles and isoindolones
11/06/2007	US7291729 Reacting 2,3,4-trifluoronitrobenzene with an alkali metal aryloxide, contacting the 3,4-difluoro-2-aryloxynitrobenzene produced with an alkali metal salt of a malonate diester to replace the 4-fluoro group with the malonate; optional further hydrolysis, reduction of the NO2 group, and decarboxylation
11/06/2007	US7291728 Spirolactams and their synthesis
11/06/2007	US7291686 Crosslinking a polymer; adapting a conformation of the polymer to a template dissolved or suspended in a solvent by interacting the polymer with the template, so as to increase the interaction enthalpy between the conformation and the template by more than 0.1 kcal/mole
11/06/2007	US7291644 For therapy and prophylaxis of allergic disorder, diseases accompanied with itching, secondary diseases generated by behaviors caused by itching, inflammation, chronic obstructive pulmonary disease, ischemic reperfusion disorder, pleuritis complicated by rheumatoid arthritis, cerebrovascular disease
11/06/2007	US7291637 4,7-Methano--, ethano-, oxy- or thio- indazol-3-ones or benzisothiazol-3-ones in which the S is mono- or dioxygenated, e.g., 3a,4,7,7a-tetrahydro-4,7-methano-1,2-benzisothiazol-3(2H)-one-1,1-dioxide; treatment of diseases such as cancer and immune disorders
11/06/2007	US7291619 Melanocortin receptor agonists
11/06/2007	US7291613 Inhibitors of p38 kinase
11/06/2007	US7291611 Including indanones, indolinones and benzoxazolinones containing a piperidine ring, e.g., 1-[3-(4-(Hydroxymethyl)piperidin-1-yl)propyl]-1,3-dihydrobenzoimidazol-2-one; particularly for the M1 and/or M4 receptor subtypes; increase acetylcholine signaling or effect in the brain
11/06/2007	US7291433 Poly(hydrazone)-based charge transport materials
11/06/2007	US7291406 Organometallic complexes as phosphorescent emitters in organic LEDS
11/06/2007	CA2266556C Nmda (n-methyl-d-aspartate) antagonists
11/06/2007	CA2241666C Tricyclic compounds, their production and use
11/06/2007	CA2223112C 1,2-bis-adducts of stable nitroxides with substituted ethylenes and stabilized compositions
11/01/2007	WO2007122745A1 N-tert-butoxycarbonyl-2-pyrrolidinones and process for producing the same
11/01/2007	WO2007122744A1 Process for producing polycyclic proline derivative or acid adduct salt thereof
11/01/2007	WO2007122743A1 Process for producing polycyclic lactam
11/01/2007	WO2007122340A1 Cationic dichromophoric compound containing two units of hydrazone type and comprising a cationic linker arm, dye composition comprising at least one such compound, method for the use thereof and uses
11/01/2007	WO2007122219A1 3- (aminomethyliden) 2-indolinone derivatives and their use as cell proliferation inhibitors
11/01/2007	WO2007121662A1 Diphenyl urea derivatives as kinase inhibitors, compositions and uses thereof
11/01/2007	WO2007121578A1 Indole amide derivatives as ep4 receptor antagonists
11/01/2007	WO2007103389A9 Aldolases, nucleic acids encoding them and methods for making and using them
11/01/2007	WO2007079239A3 Bicyclic nitrogen compounds as modulators of ghrelin receptor and uses thereof
11/01/2007	US20070255058 Heterocyclic Compounds and Optical Recording Materials
11/01/2007	US20070255056 Method for manufacture of compounds related to the class of substituted sulfonyl urea anti-diabetics
11/01/2007	US20070254942 1S)-Cyclopropanecarboxylic acid {7-chloro-2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1H-isoindol-4-yl}amide, which may further contain an anticancer agent or an antiinflammatory agent; treating atopic dermatitis, Crohn's disease, and colon cancer
11/01/2007	US20070254941 Subtantially pure ropinirole hydrochloride, polymorphic form of ropinirole and process for their preparation
11/01/2007	US20070254875 Androgen Receptor Modulator Compounds and Methods
11/01/2007	US20070254874 gastrointestinal disorders, urinary tract disorders such as hyperactive bladder, and cardiovascular disorders without side effects related to CNS activity; acid moiety makes drug unable to cross the blood-brain barrier; carboxy, phosphonic, sulfonic, or phosphoric acid derivative of piboserod (DDL-6001)

1 ... 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 ... 458